703 validation of the pac-sym questionnaire in a non-cancer pain population receiving alvimopan for opioid-induced gastrointestinal (gi) side effects

European Journal of PainVolume 10, Issue S1 p. S183c-S184 703 VALIDATION OF THE PAC-SYM QUESTIONNAIRE IN A NON-CANCER PAIN POPULATION RECEIVING ALVIMOPAN FOR OPIOID-INDUCED GASTROINTESTINAL (GI) SIDE EFFECTS T. Tusker, T. Tusker Fellbacher Str. Fellbach, GermanySearch for more papers by this authorC. Wachter, C. Wachter Fellbacher Str. Fellbach, GermanySearch for more papers by this authorB. Morlion, B. Morlion University Hospital, Leuven, BelgiumSearch for more papers by this authorN. Aggarwal, N. Aggarwal Finchgate Boulevard, Ontario, CanadaSearch for more papers by this authorL. Frank, L. Frank United BioSource Corporation, Bethesda, MDSearch for more papers by this authorA. Rentz, A. Rentz United BioSource Corporation, Bethesda, MDSearch for more papers by this authorC. Kleoudis, C. Kleoudis GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this authorT. Bell, T. Bell GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this authorA. Pierce, A. Pierce GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this authorJ. Snidow, J. Snidow GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this author T. Tusker, T. Tusker Fellbacher Str. Fellbach, GermanySearch for more papers by this authorC. Wachter, C. Wachter Fellbacher Str. Fellbach, GermanySearch for more papers by this authorB. Morlion, B. Morlion University Hospital, Leuven, BelgiumSearch for more papers by this authorN. Aggarwal, N. Aggarwal Finchgate Boulevard, Ontario, CanadaSearch for more papers by this authorL. Frank, L. Frank United BioSource Corporation, Bethesda, MDSearch for more papers by this authorA. Rentz, A. Rentz United BioSource Corporation, Bethesda, MDSearch for more papers by this authorC. Kleoudis, C. Kleoudis GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this authorT. Bell, T. Bell GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this authorA. Pierce, A. Pierce GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this authorJ. Snidow, J. Snidow GlaxoSmithKline, Research Triangle Park, NC, USASearch for more papers by this author First published: 13 January 2012 https://doi.org/10.1016/S1090-3801(06)60706-4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume10, IssueS1September 2006Pages S183c-S184 RelatedInformation